Related Experiment Video
Updated: Jul 29, 2026
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
[Interval reduction of photodynamic therapy (PDT) in age-related macular degeneration (AMD) is not advantageous. A
N Eter1, A Vogel, C Inhetvin-Hutter
1Universitäts-Augenklinik Bonn. eter@uni-bonn.de
Purpose:
To find out if carrying out PDT again 6 weeks after initial PDT will improve the results at 3 months.
Methods:
A total of 22 eyes were treated according to the dose regimen proposed by the TAP study.
Results:
After the first PDT, the CNV remained permanently closed in 14% of the eyes. Repeating the treatment 6 weeks later did not lead to permanent closure of more CNVs or a diminished size at 3 months. Short-term re-treatment had no substantial effect on the underlying choriocapillaries. Visual acuity did not profit or suffer from early re-treatment.
Conclusion:
Shortening of the treatment interval has no serious side-effects, but does not seem to improve the results reported in the TAP study.
